»» Searching for " nas "
 Related Search Tags:  Nasdaq:ZUMZ Zumiez ZUMZ Iferanserin Nasdaq:VTUS VEN309 Ventrus VentrusBiosciences VTUS Nasdaq:TRST TRST TrustCo Merck Nasdaq:THLD THLD Threshold Nasdaq:TTEK TetraTech TTEK Nasdaq:SYNL Synalloy SYNL NASDAQ:SBUX SBUX Starbucks Coffee StockWatch StandardMicrosystems Nasdaq:SMSC SMSC Animals SeattleGenetics SGEN Nasdaq:SGEN ADCETRIS Hodgkin NationalCancerInstitute USFDA Nasdaq:SDIX SDIX ANTIBODIES Antigens Live Music video Ras nas Nasibu mwanukuzi Reggae Radio Tanzania Musician
Showing Results 1-12 of 214 |  Sort by:     
Page 1 of 18  |  Go to page    Next» LAST»»
Welcome to CRWE Newswire, I’m Yohemy Auerbach. Zumiez Incorporated - symbol ZUMZ - At the ring of the closing bell reported six-teen percent increase to forty-three point five million dollars of total net sales for the five-week period ended July 2nd, 2011 compared to the same period the prior year. Zumiez’s stores that opened at least one year, increased sales by nine point eight percent. The company is a leading specialty retailer of action sports related apparel, footwear, equipment and accessories operating under the Zumiez brand name. For more information about Zumiez Incorporated - symbol ZUMZ -…visit zumiez.com. For CRWE Newswire I am Yohemy Auerbach.
Zumiez (ZUMZ) June...
Categories: Videos 
Added: 213 days ago
By: karmastock
Runtime: 0m51s
Views: 49
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Ventrus BioSciences Incorporated - symbol VTUS - reported that it has completed its acquisition of all rights and title to VEN 309 - iferanserin ointment for the treatment of symptomatic hemorrhoids - from the licensor, Sam Amer & Company. Based on a report by the National Institute of Diabetes and Digestive Kidney Diseases, the company estimates that symptomatic hemorrhoids currently affect approximately 12.5 million adults. Ventrus is a development stage specialty pharmaceutical company focused on the development of late-stage prescription drugs for gastrointestinal disorders. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
Ventrus Biosciences (VTUS)...
Categories: Videos 
Added: 76 days ago
By: karmastock
Runtime: 1m20s
Views: 81
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to watch. I am Shalika Jayasekera. On its third quarter fiscal 2011, TrustCo Bank Corporation NY - symbol TRST - posted net income of $9.2 million, a 10.4% increase year over year, average loans were up $112.8 million or 4.8% compared to the same period the prior year and average deposits rose $228.8 million or 6.6% over third quarter 2010. TrustCo Bank Corporation NY operates as the holding company for Trustco Bank. The Bank provides personal and business banking services for individuals, partnerships, corporations and other entities. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
TrustCo Bank (TRST) 3Q2011...
Categories: Videos 
Added: 105 days ago
By: karmastock
Runtime: 1m16s
Views: 10
 | Comments: 0
Not yet rated
CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones.rnrn***********************rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer). rn
Threshold Pharmaceuticals...
Categories: Videos 
Added: 1 days ago
By: karmastock
Runtime: 1m34s
Views: 2
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to watch. I am Sara Bryant. Tetra Tech Incorporated - symbol TTEK - reported that it has been awarded a contract valued at up to $55 million to continue its support for high priority pollution prevention programs, including evaluating innovative technologies and providing research and development support to the U.S. Environmental Protection Agency Office of Research and Development, National Risk Management Research Laboratory. Tetra Tech will support the development and evaluation of technologies and tools to prevent or reduce pollution of air, land, and water, and restore ecosystems. Tetra Tech is a leading provider of consulting, engineering, program management, construction, and technical services. The Company supports government and commercial clients by providing innovative solutions to complex problems focused on water, environment, energy, infrastructure, and natural resources.
Tetra Tech (TTEK) Gets...
Categories: Videos 
Added: 120 days ago
By: karmastock
Runtime: 1m28s
Views: 48
 | Comments: 0
Not yet rated
CRWENewswire, Stocks to Watch. On its fourth quarter fiscal 2011, Synalloy Corp - SYNL - posted sales of $40,241,000, a 7% increase year over year, while its Net earnings for 2011 increased 44% to $5,797,000 or $0.91 per share compared to 2010. On its Metals Segment, Sales increased 9% to $29,974,000 while operating income increased 35% to $1,948,000 in the fourth quarter of 2011 from the same period a year earlier. Synalloy Corporation is structured as a holding company, currently comprised of two major groups: Metals and Chemicals.rnrn***********************rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer). rn
Synalloy (SYNL) Metal...
Categories: Videos 
Added: 1 days ago
By: karmastock
Runtime: 0m0s
Views: 8
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to watch. I’m Sara Bryant. I know I can’t start my day correctly without a nice, hot, perfect cup of coffee, what about you? Today we are talking about . . .Starbucks Corporation - symbol SBUX - reported financial results for its fiscal third quarter ended July 3, 2011, posting total net revenues of $2.9 billion, a 12% increase year-over-year and record earnings per share of $0.36, increased 33% compared to the same period the prior year. On its fiscal 2012 targets, Starbucks plans to accelerate growth by opening approximately 800 net new stores globally, the company is targeting approximately 10% revenue growth and it expects earnings per share growth in the range of 15% to 20%. Thank you for tuning in, I’m Sara Bryant. see you soon, right here on CRWE Newswire Stocks to Watch
Starbucks (SBUX) 3QFY2011...
Categories: Videos 
Added: 190 days ago
By: karmastock
Runtime: 1m7s
Views: 6
 | Comments: 0
Not yet rated
Standard Microsystems (SMSC) Reported its First Quarter of Fiscal Year 2012 Financial Results. Highlights include: Total revenue for the first quarter 2012 was $103.5 million, an increase of approximately 7 percent compared to the same period in the prior year; the company also reported Non-GAAP gross margin of 56.4 percent and Non-GAAP earnings per share of $0.47. Looking ahead to the second quarter of fiscal 2012, the Company expects Revenue in the range of $112 to $114 million.
Standard Microsystems...
Categories: Videos 
Added: 222 days ago
By: karmastock
Runtime: 1m22s
Views: 96
 | Comments: 0
Not yet rated
Funny Africa - Simba wanasubiri swala.....
Simba vs Swala
Categories: Videos 
Added: 1295 days ago
By: Netgear
Runtime: 0m14s
Views: 738
 | Comments: 2
Not yet rated
Thank you for joining us. I am your host Yohemy Auerbach at CRWE Newswire Stocks to watch. Seattle Genetics Incorporated - symbol SGEN - reported that the U.S. FDA has granted accelerated approval of ADCETRIS. ADCETRIS is the first approved by the FDA for Hodgkin lymphoma in more than 30 years, and provides a new therapeutic alternative for Hodgkin lymphoma and systemic anaplastic large cell lymphoma in these settings. Lymphoma is a general term for a group of cancers that originate in the lymphatic system. According to the National Cancer Institute, Estimated 8,830 new cases and 1,300 deaths from Hodgkin lymphoma in the United States in 2011. Seattle Genetics has U.S. and Canadian commercialization rights for adcetris. The company expects to make ADCETRIS available to patients in the next week. Thank you for tuning in, have a great day. For CRWE Newswire, Stocks to watch, I’m Yohemy Auerbach.
Seattle Genetics (SGEN)...
Categories: Videos 
Added: 168 days ago
By: karmastock
Runtime: 1m32s
Views: 48
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. SDIX - symbol SDIX - reported that it has successfully completed its previously announced sale of the assets of its water quality division to Modern Water plc for $4.5 million. According to the company, the net cash from this sale strengthens its balance sheet and provides additional resources for key investments. SDIX is a biotechnology company with a core expertise in creating better antigens, better antibodies and better assays for the pharmaceutical, biotechnology and food safety markets. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
SDIX Completes Sale of...
Categories: Videos 
Added: 56 days ago
By: karmastock
Runtime: 1m3s
Views: 21
 | Comments: 0
Not yet rated
This live music video by Ras Nas aka Nasibu Mwanukuzi was shot during a live radio concert in Oslo, Norway. Ras Nas is a musician and poet from Tanzania
River Nile - Dub reggae...
Categories: Videos 
Added: 1127 days ago
By: Kongoi
Runtime: 6m22s
Views: 953
 | Comments: 0
Not yet rated
Page 1 of 18  |  Go to page    Next» LAST»»
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0397 seconds.